Reportlinker Adds Facial Aesthetics (Botox, Dermal Fillers, Collagen Products) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, April 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Facial Aesthetics (Botox, Dermal Fillers, Collagen Products) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Facial Aesthetics (Botox, Dermal Fillers, Collagen Products) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global facial aesthetics market. The report provides market landscape, competitive landscape and market trends information on the facial aesthetics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include botulinum toxin, hyaluronic acid, particle and polymer fillers, and collagens.
- Annualized market revenues data for 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within facial aesthetics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Allergan, Q-Med AB, Mentor Corporation, Medicis and BioForm Medical.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the facial aesthetics market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the facial aesthetics market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global facial aesthetics market and the factors shaping it.
1 Table of contents
1 Table of contents 1
1.1 List of Tables 3
1.2 List of Figures 4
2 Executive Summary 5
3 Introduction 8
3.1 GlobalData Report Guidance 8
4 Facial Aesthetics – Device Overview 9
4.1 Botulinum Toxin 9
4.2 Hyaluronic Acid Based Dermal Fillers 9
4.3 Particle and Polymer Based Dermal Fillers 9
4.4 Collagen Products 9
5 Facial Aesthetics, Market Characterization 10
5.1 Facial Aesthetics Market, Global, Revenue ($m), Forecast, 2010-2016 10
5.2 Facial Aesthetics Market, Key Trends 10
5.2.1 Hyaluronic Acid Based Dermal Fillers to Drive the Market for Facial Aesthetics in the Future 10
5.2.2 Dermal Fillers Derived from Marine Algae are Expected to Drive Future Growth in the Facial Aesthetics Market 11
5.3 Facial Aesthetics, Market Dynamics 11
5.3.1 Market Drivers 11
5.3.2 Market Restraints 13
6 Facial Aesthetics Market – Segment Analysis 14
6.1 Botulinum Toxin, Global, Revenue ($m), Forecast, 2010–2017 14
6.2 Botulinum Toxin, Market Dynamics 15
6.2.1 Increasing Number of Procedures and Reducing Price Trend to be the Key Drivers for Increasing Botulinum Toxin Procedures 15
6.2.2 High Side Effects Profile and Temporary Results are the Major Restraints for the Growth of Botulinum Toxin Market 16
6.3 Hyaluronic Acid Based Dermal Fillers, Global, Revenue ($m), Forecast, 2010–2017 16
6.4 Hyaluronic Acid Based Dermal Fillers, Market Dynamics 17
6.4.1 Low Side Effects Profile and Recurring Revenue due to Multiple Treatments to be the Key Drivers for Growth in Procedures Using Hyaluronic Acid Based Dermal Fillers 17
6.4.2 Increasing Preference for Botulinum Toxin is the Major Restraint for Hyaluronic Acid Based Dermal Fillers 18
6.5 Particle and Polymer Fillers, Global, Revenue ($m), Forecast, 2010–2017 18
6.6 Particle and Polymer Based Dermal Fillers, Market Dynamics 19
6.6.1 Long Term Results, the Key Driver for Increase in Procedures Using Particle and Polymer Based Dermal Fillers 19
6.6.2 High Side Effects Profile and Cost is a Major Restraint for the Growth of Particle and Polymer Fillers Market 20
6.7 Collagen Products, Global, Revenue ($m), Forecast, 2010-2017 20
6.8 Collagen Products, Market Dynamics 21
6.8.1 Increasing Preference for Hyaluronic Acid Based Dermal Fillers has led to the Decline of Collagen Products 21
7 Facial Aesthetics Market, by Country, 2010–2017 22
7.1 Facial Aesthetics Market, the US, Revenue ($m), Forecast, 2010–2017 22
7.2 Facial Aesthetics Market, the UK, Revenue ($m), Forecast, 2010–2017 24
7.3 Facial Aesthetics Market, Germany, Revenue ($m), Forecast, 2010–2017 26
7.4 Facial Aesthetics Market, France, Revenue ($m), Forecast, 2010–2017 28
7.5 Facial Aesthetics Market, Italy, Revenue ($m), Forecast, 2010–2017 30
7.6 Facial Aesthetics Market, Spain, Revenue ($m), Forecast, 2010–2017 32
7.7 Facial Aesthetics Market, Japan, Revenue ($m), Forecast, 2010–2017 34
7.8 Facial Aesthetics Market, China, Revenue ($m), Forecast, 2010–2017 36
7.9 Facial Aesthetics Market, India, Revenue ($m), Forecast, 2010–2017 38
7.10 Facial Aesthetics Market, Australia, Revenue ($m), Forecast, 2010–2017 40
7.11 Facial Aesthetics Market, Brazil, Revenue ($m), Forecast, 2010–2017 42
8 Facial Aesthetics Market – Strategic Competitive Assessment 44
8.1 Facial Aesthetics Market, the US, Company Share, 2010 44
8.2 Facial Aesthetics Market, Europe, Company Share, 2010 45
8.3 Facial Aesthetics Market, Asia-Pacific, Company Share, 2010 46
8.4 Facial Aesthetics Market, Key Market Participants 48
8.4.1 Allergan, Inc 48
8.4.2 Q–Med AB 50
8.4.3 Mentor Corporation 51
8.4.4 Medicis Pharmaceuticals Corporation 54
8.4.5 BioForm Medical, Inc 55
9 Facial Aesthetics Market – Strategic Pipeline Assessment 58
9.1 Facial Aesthetics Market, Pipeline Assessment, by Development Stage 58
9.2 Profiles of Pipeline Products in Facial Aesthetics Market 61
9.2.1 Contura International A/S: Aquamid 61
9.2.2 Celltrix AB: Credurance 61
9.2.3 Albiorex: Humallagen Dermal Filler 61
9.2.4 Allergan, Inc.: Juvederm Voluma 62
9.2.5 Q-Med AB: Macrolane 62
9.2.6 Genzyme Corporation: NADGL 63
9.2.7 Anika Therapeutics, Inc.: Next Generation ELEVESS Dermal Filler 63
9.2.8 Merz GmbH & Co. KGaA: Novabel-Dermal Bead 63
9.2.9 Prollenium Medical Technologies, Inc: Revanesse Ultra 64
9.2.10 JUVENIS LTD.: Tenergel 64
9.2.11 FibroGen, Inc.: FG-5030 64
9.2.12 TEI Biosciences Inc.: Injectable Dermal Filler 65
9.2.13 Revance Therapeutics, Inc.: RT001 65
9.2.14 Merz Pharmaceuticals Inc.: NT-201 65
10 Appendix 66
10.1 Definitions 66
10.1.1 Facial Aesthetics 66
10.2 Acronyms 66
10.3 Sources 67
10.4 Research Methodology 67
10.5 Secondary Research 67
10.6 Primary Research 67
10.7 Models 68
10.8 Forecasts 68
10.9 Expert Panels 68
10.10 GlobalData Consulting 68
10.11 Contact Us 69
10.12 Disclaimer 69
1.1 List of Tables
Table 1: Facial Aesthetics Market, Global, Revenue ($m), 2010–2017 10
Table 2: Botulinum Toxin, Global, Revenue ($m), 2010–2017 14
Table 3: Botulinum Toxin Market, Global, Procedures (million), 2010–2017 15
Table 4: Hyaluronic Acid Based Dermal Fillers, Global, Revenue ($m), 2010–2017 16
Table 5: Hyaluronic Acid Based Dermal Fillers Market, Global, Procedures (million), 2010–2017 17
Table 6: Particle and Polymer Fillers, Global, Revenue ($m), 2010–2017 18
Table 7: Particle and Polymer Based Dermal Fillers Market, Global, Procedures (000's), 2010–2017 19
Table 8: Collagen Products, Global, Revenue ($m), 2010–2017 20
Table 9: Facial Aesthetics Market, the US, Revenue ($m), 2010–2017 22
Table 10: Facial Aesthetics Market, the US, Procedures (000's), 2010 23
Table 11: Facial Aesthetics Market, the UK, Revenue ($m), 2010–2017 24
Table 12: Facial Aesthetics Market, the UK, Procedures (000's), 2010 25
Table 13: Facial Aesthetics Market, Germany, Revenue ($m), 2010–2017 26
Table 14: Facial Aesthetics Market, Germany, Procedures (000's), 2010 27
Table 15: Facial Aesthetics Market, France, Revenue ($m), 2010–2017 28
Table 16: Facial Aesthetics Market, France, Procedures (000's), 2010 29
Table 17: Facial Aesthetics Market, Italy, Revenue ($m), 2010–2017 30
Table 18: Facial Aesthetics Market, Italy, Procedures (000's), 2010 31
Table 19: Facial Aesthetics Market, Spain, Revenue ($m), 2010–2017 32
Table 20: Facial Aesthetics Market, Spain, Procedures (000's), 2010 33
Table 21: Facial Aesthetics Market, Japan, Revenue ($m), 2010–2017 34
Table 22: Facial Aesthetics Market, Japan, Procedures (000's), 2010 35
Table 23: Facial Aesthetics Market, China, Revenue ($m), 2010–2017 36
Table 24: Facial Aesthetics Market, China, Procedures (000's), 2010 37
Table 25: Facial Aesthetics Market, India, Revenue ($m), 2010–2017 38
Table 26: Facial Aesthetics Market, India, Procedures (000's), 2010 39
Table 27: Facial Aesthetics Market, Australia, Revenue ($m), 2010–2017 40
Table 28: Facial Aesthetics Market, Australia, Procedures (000's), 2010 41
Table 29: Facial Aesthetics Market, Brazil, Revenue ($m), 2010–2017 42
Table 30: Facial Aesthetics Market, Brazil, Procedures (000's), 2010 43
Table 31: Facial Aesthetics Market, the US, Company Share, Revenue ($m), 2010 44
Table 32: Facial Aesthetics Market, Europe, Company Share, Revenue ($m), 2010 45
Table 33: Facial Aesthetics Market, Asia-Pacific, Company Share, Revenue ($m), 2010 46
Table 34: Allergan, Marketed Products, Applications, Features and Benefits, 2010 49
Table 35: Allergan Inc., Acquires Groupe Corneal Laboratories SA, 2007 49
Table 36: Q–Med AB, Marketed Products, Applications, Features and Benefits, 2010 50
Table 37: Galderma to Acquire Q–Med AB, 2010 50
Table 38: Mentor Corporation, Marketed Products, Applications, Features and Benefits, 2010 52
Table 39: Johnson & Johnson Acquires Mentor Corporation, 2009 52
Table 40: Medicis, Marketed Products, Applications, Features and Benefits, 2010 54
Table 41: BioForm Medical, Marketed Products, Applications, Features and Benefits, 2010 55
Table 42: Merz Pharma Completes The Acquisition of BioForm Medical, 2010 57
Table 43: Facial Aesthetics Market, List of Pipeline Products, Global, 2010 60
Table 44: Aquamid, Product Status 61
Table 45: Credurance, Product Status 61
Table 46: Humallagen Dermal Filler, Product Status 62
Table 47: Juvederm Voluma, Product Status 62
Table 48: Macrolane, Product Status 62
Table 49: NADGL, Product Status 63
Table 50: Next Generation ELEVESS Dermal Filler, Product Status 63
Table 51: Novabel–Dermal Bead, Product Status 63
Table 52: Revanesse Ultra, Product Status 64
Table 53: Novabel–Dermal Bead, Product Status 64
Table 54: FG-5030, Product Status 64
Table 55: Injectable Dermal Filler, Product Status 65
Table 56: RT001, Product Status 65
Table 57: NT-201, Product Status 65
1.2 List of Figures
Figure 1: Facial Aesthetics Market, Global, Revenue ($m), 2010–2017 10
Figure 2: Facial Aesthetics Market, Market Dynamics 11
Figure 3: Botulinum Toxin, Global, Revenue ($m), 2010–2017 14
Figure 4: Botulinum Toxin Market, Global, Procedures (million), 2010–2017 15
Figure 5: Hyaluronic Acid Based Dermal Fillers, Global, Revenue ($m), 2010–2017 16
Figure 6: Hyaluronic Acid Based Dermal Fillers Market, Global, Procedures (million), 2010–2017 17
Figure 7: Particle and Polymer Fillers, Global, Revenue ($m), 2010–2017 18
Figure 8: Particle and Polymer Based Dermal Fillers Market, Global, Procedures (000's), 2010–2017 19
Figure 9: Collagen Products, Global, Revenue ($m), 2010–2017 20
Figure 10: Facial Aesthetics Market, the US, Revenue ($m), 2010–2017 22
Figure 11: Facial Aesthetics Market, the US, Procedures (000's), 2010 23
Figure 12: Facial Aesthetics Market, the UK, Revenue ($m), 2010–2017 24
Figure 13: Facial Aesthetics Market, the UK, Procedures (000's), 2010 25
Figure 14: Facial Aesthetics Market, Germany, Revenue ($m), 2010–2017 26
Figure 15: Facial Aesthetics Market, Germany, Procedures (000's), 2010 27
Figure 16: Facial Aesthetics Market, France, Revenue ($m), 2010–2017 28
Figure 17: Facial Aesthetics Market, France, Procedures (000's), 2010 29
Figure 18: Facial Aesthetics Market, Italy, Revenue ($m), 2010–2017 30
Figure 19: Facial Aesthetics Market, Italy, Procedures (000's), 2010 31
Figure 20: Facial Aesthetics Market, Spain, Revenue ($m), 2010–2017 32
Figure 21: Facial Aesthetics Market, Spain, Procedures (000's), 2010 33
Figure 22: Facial Aesthetics Market, Japan, Revenue ($m), 2010–2017 34
Figure 23: Facial Aesthetics Market, Japan, Procedures (000's), 2010 35
Figure 24: Facial Aesthetics Market, China, Revenue ($m), 2010–2017 36
Figure 25: Facial Aesthetics Market, China, Procedures (000's), 2010 37
Figure 26: Facial Aesthetics Market, India, Revenue ($m), 2010–2017 38
Figure 27: Facial Aesthetics Market, India, Procedures (000's), 2010 39
Figure 28: Facial Aesthetics Market, Australia, Revenue ($m), 2010–2017 40
Figure 29: Facial Aesthetics Market, Australia, Procedures (000's), 2010 41
Figure 30: Facial Aesthetics Market, Brazil, Revenue ($m), 2010–2017 42
Figure 31: Facial Aesthetics Market, Brazil, Procedures (000's), 2010 43
Figure 32: Facial Aesthetics Market, the US, Company Share, 2010 44
Figure 33: Facial Aesthetics Market, Europe, Company Share, 2010 45
Figure 34: Facial Aesthetics Market, Asia-Pacific, Company Share, 2010 46
Figure 35: Botulinum Toxin Product Benchmarking 46
Figure 36: Hyaluronic Acid Based Dermal Fillers Product Benchmarking 47
Figure 37: Allergan, Inc. SWOT Analysis 48
Figure 38: Q-Med AB, SWOT Analysis 50
Figure 39: Mentor Corporation, SWOT Analysis 51
Figure 40: Medicis Pharmaceutical Corporation, SWOT Analysis 54
Figure 41: BioForm Medical, Inc., SWOT Analysis 56
Figure 42: Facial Aesthetics Market, Pipeline Assessment, by Development Stage 58
Figure 43: Facial Aesthetics Market, Pipeline Assessment, by Unmet Need 59Allergan, Inc
Q–Med AB
Mentor Corporation
Medicis Pharmaceuticals Corporation
BioForm Medical, Inc
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article